Athenex announces quantum leap healthcare collaborative reports positive trial result of i-spy2 trial for oral paclitaxel in combination with pd-1 and carboplatin in neoadjuvant breast cancer

Oral paclitaxel combination regimen has graduated in this phase 2 trial in the triple negative breast cancer subgroup oral paclitaxel combination regimen has graduated in this phase 2 trial in the triple negative breast cancer subgroup
ATNX Ratings Summary
ATNX Quant Ranking